18F-Fluorodeoxyglucose-positron emission tomography: A new explorative perspective

Experimental Gerontology

Volumn 38, Issue 4, 2003, Pages 463-470

  Schirmer, M ^a   Calamia, K T ^b   Wenger, M ^c   Klauser, A ^c   Salvarani, C ^d   Moncayo, R ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MAYO CLINIC   (United States)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d Division of Rheumatology   (Italy)

Author keywords

Autoimmune disease; Diagnosis; Imaging technique; Inflammation; Radionuclide

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; 8 QUINOLINOL INDIUM IN 111; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; NEUTROPHIL CYTOPLASMIC ANTIBODY; TECHNETIUM 99M; THALLIUM CHLORIDE TL 201; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ALZHEIMER DISEASE; ANGIOGRAPHY; AORTA ARCH SYNDROME; ARTERITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHCET DISEASE; BIOPSY; CELL LABELING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG UPTAKE; EARLY DIAGNOSIS; GIANT CELL ARTERITIS; GREAT BLOOD VESSEL; HEART MUSCLE PERFUSION; HUMAN; IMAGING SYSTEM; IMMUNOASSAY; INFLAMMATION; INTERMETHOD COMPARISON; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PATIENT; POLYARTERITIS NODOSA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RADIOISOTOPE DECAY; RHEUMATIC POLYMYALGIA; SCINTIGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TECHNIQUE; VASCULITIS; WEGENER GRANULOMATOSIS; AGED; ANIMAL; ANIMAL MODEL; AORTA ANEURYSM; ARTERIOSCLEROSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GERIATRICS; METHODOLOGY; REVIEW; SCINTISCANNING;

ANIMALIA;

AGED; ALZHEIMER DISEASE; ANIMALS; AORTIC ANEURYSM; ARTERIOSCLEROSIS; AUTOIMMUNE DISEASES; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; GERIATRICS; HUMANS; INFLAMMATION; MODELS, ANIMAL; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037380750     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00267-X     Document Type: Article

References (57)

1. Aboagye E.O., Price P.M., Jones T. In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography. Drug Discuss. Today. 6:2001;293-302.
2. Alavi A., Zhuang H. Finding infections-help from PET. Lancet. 358:2001;1386.
3. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: A potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry. 159:2002;738-745.
4. Bhatnagar A., Hustinx R., Alavi A. Nuclear imaging methods for non-invasive drug monitoring. Adv. Drug Delivery Rev. 41:2000;41-54.
5. Blockmans D., Maes A., Stroobants S., Nuyts J., Bormans G., Knockaert D., Bobbaers H., Lortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology. 38:1999;444-447.
6. Blockmans D., Stroobants S., Maes A., Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: Evidence for inflammation of the aortic arch. Am. J. Med. 108:2000;246-249.
7. Blockmans D., Knockaert D., Maes A., De Caestecker J., Stroobants S., Bobbaers H., Mortelmans L. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin. Infect. Dis. 32:2001;191-196.
8. Blockmans D., Van Moer E., Dehem J., Feys C., Mortelmans L. Positron emission tomography can reveal abdominal periaortitis. Clin. Nucl. Med. 27:2002;211-212.
9. Brix G., Nosske D., Glatting G., Minkov V., Reske S.N. A survey of PET activity in Germany during (1999). Eur. J. Nucl. Med. Mol. Imaging. 29:2002;1091-1097.
10. Calamia K.T., Hunder G.G. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum. 24:1981;1414-1418.
11. DeCarli C. The role of neuroimaging in dementia. Clin. Geriatr. Med. 17:2001;255-279.
12. Delbeke D., Patton J.A., Martin W.H., Sandler M.P. FDG PET and dual-headed gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J. Nucl. Med. 40:1999;110-117.
13. De Winter F., Petrovic M., Van de Wiele C., Vogelaers D., Afschrift M., Dierckx R.A. Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography. Clin. Nucl. Med. 25:2000;633-634.
14. 18F-Fluorodeoxyglucose triple-headed coincidence detection imaging in oncology: Preliminary results and comparison with dedicated PET. Med. Sci. Monit. 8:2002;89-94.
15. Eberling J.L., Roberts J.A., Rapp P.R., Tuszynski M.H., Jagust W.J. Cerebral glucose metabolism and memory in aged rhesus macaques. Neurobiol. Aging. 18:1997;437-443.
16. 18F-FDG-PET with a modified SPET-camera using molecular coincidence detection. Nucl. Med. Commun. 20:1999;1009-1015.
17. Erler H., Gruber J., Riccabona G., Moncayo R. Detection of vasculitis by FDG-PET using MCD. Clin. Positron Imaging. 2:1999;350.
18. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann. Intern. Med. 122:1995;502-507.
19. Forstrom L.A., Dunn W.L., Mullan B.P., Hung J.C., Lowe V.J., Thorson L.M. Biodistribution and dosimetry of [18F]fluorodeoxyglucose labelled leukocytes in normal human subjects. Nucl. Med. Commun. 23:2002;721-725.
20. Hara M., Goodman P.C., Leder R.A. FDG-PET finding in early-phase Takayasu arteritis. J. Comp. Assist. Tomogr. 23:1999;16-18.
21. Kao C.H., Ho Y.J., Lan J.L., Changlai S.P., Liao K.K., Chieng P.U. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum. 42:1999;61-68.
22. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., Stevens J.C. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56:2001;1143-1153.
23. Kubota R., Kubota K., Yamada S., Tada M., Ido T., Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J. Nucl. Med. 35:1994;104-112.
24. Marienhagen J., Geissler A., Lang B. High resolution single photon emission computed tomography of the brain in Wegener's granulomatosis. J. Rheumatol. 23:1996;1828-1830.
25. Matsuda H., Kitayama N., Ohnishi T., Asada T., Nakano S., Sakamoto S., Imabayashi E., Katoh A. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nucl. Med. 43:2002;304-311.
26. Mineura K., Sasajima T., Kowada M., Shishido F., Uemura K., Nagata K. Sequential PET studies in neuro-Behcet's syndrome. J. Neurol. 236:1989;367-370.
27. Moncayo R., Kowald E., Schauer N., Pachinger O., Schmuth M., Fritsch P., Riccabona G., Sepp N. Detection of myocardial involvement in systemic lupus erythematosus: Mismatch between normal perfusion scans with 201Thallium and pathological 18FDG uptake. Intern. Angiol. 20:2001;314-321.
28. Mossberg K.A., Taegtmeyer H. Time course of skeletal muscle glucose uptake during euglycemic hyperinsulinemia in the anesthetized rabbit: A fluorine-18-2-deoxy-2-fluoro-D-glucose study. J. Nucl. Med. 33:1992;1523-1529.
29. Murthy K., Aznar M., Thompson C.J., Loutfi A., Lisbona R., Gagnon J.H. Results of preliminary clinical trials of the positron emission mammography system PEM-I: A dedicated breast imaging system producing glucose metabolic images using FDG. J. Nucl. Med. 41:2000;1851-1858.
30. Noda A., Ohba H., Kakiuchi T., Futatsubashi M., Tsukada H., Nishimura S. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys. Brain Res. 936:2002;76-81.
31. O'Doherty M.J., Marsden P.K. Being equipped for clinical PET. Lancet. 356:2000;1701-1703.
32. Paik J.Y., Lee K.H., Byun S.S., Choe Y.S., Kim B.T. Use of insulin to improve [18F]fluorodeoxyglucose labelling and retention for in vivo positron emission tomography imaging of monocyte trafficking. Nucl. Med. Commun. 23:2002;551-557.
33. Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., Johnstrom P., Davenport A.P., Kirkpatrick P.J., Arch B.N., Pickard J.D., Weissberg P.L. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 105:2002;2708-2711.
34. Sailer M., Burchert W., Ehrenheim C., Smid H.G., Haas J., Wildhagen K., Wuster U., Deicher H. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus. J. Neurol. 244:1997;186-193.
35. Sakalihasan N., Van Damme H., Gomez P., Rigo P., Lapiere C.M., Nusgens B., Limet R. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur. J. Vasc. Endovasc. Surg. 23:2002;431-436.
36. Sakamoto S., Ishii K., Sasaki M., Hosaka K., Mori T., Matsui M., Hirono N., Mori E. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J. Neurol. Sci. 200:2002;27-32.
37. Salvarani C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N. Engl. J. Med. 347:2002;261-271.
38. Schirmer M., Calamia K.T., O'Duffy J.D. Is there a place for large vessel disease in the diagnostic criteria of Behcet's disease? J. Rheumatol. 26:1999;2511-2512.
39. Stanson A.W. Roentgenographic findings in major vasculitic syndromes. Rheum. Dis. Clin. North. Am. 16:1990;293-308.
40. Stoppe G., Wildhagen K., Seidel J.W., Meyer G.J., Schober O., Heintz P., Kunkel H., Deicher H., Hundeshagen H. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology. 40:1990;304-308.
41. Tahiro M., Kubota K., Itoh M., Moser E. Trends in use of positron emission tomography. Lancet. 357:2001;886.
42. Terada T. Magnetic resonance imaging in neuro-Behcet's disease-comparison with clinical, X-ray CT, and PET findings. Ryumachi. 31:1991;175-183.
43. Theron J., Tyler J.L. Takayasu's arteritis of the aortic arch: Endovascular treatment and correlation with positron emission tomography. Am. J. Neuroradiol. 8:1987;621-626.
44. Tsukada H., Kakiuchi T., Fukumoto D., Nishiyama S., Koga K. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: A PET study in conscious monkeys. Brain Res. 862:2000;180-186.
45. Turlakow A., Yeung H.W.D., Pui J., Macapinlac H., Liebovitz E., Rusch V., Goy A., Larson S.M. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch. Intern. Med. 161:2001;1003-1007.
46. Van Dam A.P. Diagnosis and pathogenesis of CNS lupus. Rheumatol. Int. 11:1991;1-11.
47. Varma A.R., Adams W., Lloyd J.J., Carson K.J., Snowden J.S., Testa H.J., Jackson A., Neary D. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol. Scand. 105:2002;261-269.
48. Weber W.A., Neverve J., Sklarek J., Ziegler S.I., Bartenstein P., King B., Treumann T., Enterrottacher A., Krapf M., Haussinger K.E., Lichte H., Prauer H.W., Thetter O., Schwaiger M. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: Comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system. Eur. J. Nucl. Med. 26:1999;388-395.
49. Weiner S.M., Otte A., Schumacher M., Brink I., Juengling F.D., Sobanksi T., Nitzsche E.U., Peter H.H. Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus. Lupus. 9:2000;386-389.
50. Weyand C.M., Fulbright J.W., Evans J.M., Hunder G.G., Goronzy J.J. Corticosteroid requirements in polymyalgia rheumatica. Arch. Intern. Med. 159:1999;577-584.
51. Wick G., Perschinka H., Millonig G. Atherosclerosis as an autoimmune disease: An update. Trends Immunol. 22:2001;665-669.
52. Wildhagen K., Meyer G.J., Stoppe G., Heintz P., Deicher H., Hundeshagen H. PET and MR imaging in a neuro-Behcet syndrome. Eur. J. Nucl. Med. 15:1989;746-764.
53. Wildhagen K., Stoppe G., Meyer G.J., Heintz P., Hundeshagen H., Deicher H. Imaging diagnosis of central nervous system involvement in panarteritis nodosa. Z. Rheumatol. 48:1989;323-325.
54. Wilke W.S. Large vessel vasculitis (giant cell arteritis, Takayasu arteritis). Baillieres Clin. Rheumatol. 11:1997;285-313.
55. Yamamoto M., Suhara T., Okubo Y., Ichimiya T., Sudo Y., Inoue M., Takano A., Yasuno F., Yoshikawa K., Tanada S. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sci. 71:2002;751-757.
56. Zhang H., Tian M., Oriuchi N., Higuchi T., Tanada S., Endo K. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET. Br. J. Radiol. 75:2002;409-416.
57. Zouboulis C.C. Epidemiology of Adamantiades-Behcet's disease. Ann. Med. Interne (Paris). 150:1999;488-498.